Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04155 (
pS2
)
1,234
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nuclear receptors (NRs) regulate target gene transcription through the recruitment of multiple coactivator complexes to the promoter regions of target genes. One important coactivator complex includes a p160 coactivator (GRIP1, SRC-1, or ACTR) and its downstream coactivators (e.g., p300, CARM1, CoCoA, and Fli-I), which contribute to transcriptional activation by protein acetylation, protein methylation, and protein-protein interactions. In this study, we identified a novel NR coactivator,
GAC63
, which binds to the N-terminal region of p160 coactivators as well as the ligand binding domains of some NRs.
GAC63
enhanced transcriptional activation by NRs in a hormone-dependent and GRIP1-dependent manner in transient transfection assays and cooperated synergistically and selectively with other NR coactivators, including GRIP1 and CARM1, to enhance estrogen receptor function. Endogenous
GAC63
was recruited to the estrogen-responsive
pS2
gene promoter of MCF-7 cells in response to the hormone. Reduction of the endogenous
GAC63
level by small interfering RNA inhibited transcriptional activation by the hormone-activated estrogen receptor. Thus,
GAC63
is a physiologically relevant part of the p160 coactivator signaling pathway that mediates transcriptional activation by NRs.
...
PMID:GAC63, a GRIP1-dependent nuclear receptor coactivator. 1598 12